Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
- PMID: 10229227
- DOI: 10.1038/8394
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
Abstract
Combination therapy for HIV-1 infection can reduce plasma virus to undetectable levels, indicating that prolonged treatment might eradicate the infection. However, HIV-1 can persist in a latent form in resting CD4+ T cells. We measured the decay rate of this latent reservoir in 34 treated adults whose plasma virus levels were undetectable. The mean half-life of the latent reservoir was very long (43.9 months). If the latent reservoir consists of only 1 x 10(5) cells, eradication could take as long as 60 years. Thus, latent infection of resting CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective anti-retroviral therapy.
Comment in
-
HIV-1 and HAART: a time to cure, a time to kill.Nat Med. 1999 Jun;5(6):609-11. doi: 10.1038/9452. Nat Med. 1999. PMID: 10371490 No abstract available.
-
The QUEST trial, a paradigm of HIV collaborative research.Nat Med. 2000 Nov;6(11):1194. doi: 10.1038/81251. Nat Med. 2000. PMID: 11062508 No abstract available.
Similar articles
-
The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.Nat Med. 2000 Jan;6(1):82-5. doi: 10.1038/71577. Nat Med. 2000. PMID: 10613829
-
Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.N Engl J Med. 1999 May 27;340(21):1605-13. doi: 10.1056/NEJM199905273402101. N Engl J Med. 1999. PMID: 10341272 Clinical Trial.
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
-
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.Nature. 1997 May 8;387(6629):183-8. doi: 10.1038/387183a0. Nature. 1997. PMID: 9144289
-
Inducible HIV RNA transcription assays to measure HIV persistence: pros and cons of a compromise.Retrovirology. 2018 Jan 17;15(1):9. doi: 10.1186/s12977-017-0385-y. Retrovirology. 2018. PMID: 29343255 Free PMC article. Review.
Cited by
-
Effect of Opioid Use on Immune Activation and HIV Persistence on ART.J Neuroimmune Pharmacol. 2020 Dec;15(4):643-657. doi: 10.1007/s11481-020-09959-y. Epub 2020 Sep 25. J Neuroimmune Pharmacol. 2020. PMID: 32974750 Free PMC article. Review.
-
Successful isolation of infectious and high titer human monocyte-derived HIV-1 from two subjects with discontinued therapy.PLoS One. 2013 May 31;8(5):e65071. doi: 10.1371/journal.pone.0065071. Print 2013. PLoS One. 2013. PMID: 23741458 Free PMC article.
-
Gesicles packaging dCas9-VPR ribonucleoprotein complexes can combine with vorinostat and promote HIV proviral transcription.Mol Ther Methods Clin Dev. 2024 Feb 2;32(1):101203. doi: 10.1016/j.omtm.2024.101203. eCollection 2024 Mar 14. Mol Ther Methods Clin Dev. 2024. PMID: 38390557 Free PMC article.
-
Genome editing for clinical HIV isolates.Nat Biotechnol. 2016 Apr;34(4):388-9. doi: 10.1038/nbt.3531. Nat Biotechnol. 2016. PMID: 27054991 No abstract available.
-
Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.Clin Microbiol Rev. 2016 Oct;29(4):859-80. doi: 10.1128/CMR.00015-16. Clin Microbiol Rev. 2016. PMID: 27559075 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials